Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries Ltd has submitted a compliance certificate to BSE under SEBI's Regulation 74(5) for the quarter ended 31 December 2025. The certificate has been issued by the company's Registrar & Share Transfer Agent (RTA), Satellite Corporate Services Private Limited. It confirms that all securities are listed on the stock exchange and that physical share certificates, upon dematerialization, have been mutilated and cancelled with the depository's name recorded as the registered owner. Importantly, the RTA has noted that no physical certificates were received for dematerialization during the quarter. This is a routine, periodic regulatory filing and does not involve any corporate action or financial event.
No impact on shareholders or stock price. This is a standard quarterly compliance submission confirming the status of physical-to-demat share transfers, with no activity reported in this period.